Cargando…

The High Cost of Diabetes Drugs: Disparate Impact on the Most Vulnerable Patients

Detalles Bibliográficos
Autor principal:	Taylor, Simeon I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2020
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051261/ https://www.ncbi.nlm.nih.gov/pubmed/32958616 http://dx.doi.org/10.2337/dci20-0039

Ejemplares similares

Are vaccines against COVID-19 tailored to the most vulnerable people?
por: Antonelli Incalzi, Raffaele, et al.
Publicado: (2021)

Healthcare disparities amongst vulnerable populations of Arabs and Jews in Israel
por: Shadmi, Efrat
Publicado: (2018)

Mind the Gap: Disparity Between Research Funding and Costs of Care for Diabetic Foot Ulcers
por: Armstrong, David G., et al.
Publicado: (2013)

Forty-Five Years of Research and Progress in Breast Cancer: Progress for Some, Disparities for Most
por: Hoxha, Ilir, et al.
Publicado: (2022)

Building back fairer in public health policy requires collective action with and for the most vulnerable in society
por: D'Ambruoso, Lucia, et al.
Publicado: (2021)

Advancing Control of Cholera in the Interest of the Most Vulnerable in our Global Society
por: Ivers, Louise C
Publicado: (2018)

The Downstream Impacts of High Drug Costs for PrEP Have Hindered the Promise of HIV Prevention
por: Farrow, Kenyon
Publicado: (2022)

Drug costs in context: assessing drug costs in cost-of-illness analyses
por: Mattingly, T Joseph, et al.
Publicado: (2022)

New race and ethnicity standards: elucidating health disparities in diabetes
por: Katzmarzyk, Peter T, et al.
Publicado: (2012)

Age, frailty and diabetes – triple jeopardy for vulnerability to COVID-19 infection
por: Sinclair, A.J., et al.
Publicado: (2020)

Maintaining progress for the most beautiful chart in the world
por: Hay, Simon I
Publicado: (2019)

Making the most of common impact metrics: promising approaches that need further study
por: Grove, John, et al.
Publicado: (2013)

Elderly African Americans: The vulnerable of the vulnerable in the COVID‐19 era
por: Bhandari, Sanjay, et al.
Publicado: (2020)

The Most Vulnerable Leaders in the Community
por: Rissman, Lauren
Publicado: (2021)

Linking Coronary Microvascular and Cardiac Diastolic Dysfunction in Diabetes: Are Women More Vulnerable?
por: Bender, Shawn B.
Publicado: (2019)

Health impact of human rights testimony: harming the most vulnerable?
por: Meffert, Susan M, et al.
Publicado: (2016)

Endless forms most beautiful
por: Nel, Jeremy
Publicado: (2022)

Long-term Outcome with Paclitaxel Drug-coated Balloon in the Real World: Focus on Those Most at Risk
por: Teichgräber, Ulf
Publicado: (2023)

Rethinking the use of ‘vulnerable’
por: Munari, Stephanie C., et al.
Publicado: (2021)

Smarter Modeling to Enable a Smarter Insulin
por: Taylor, Simeon I., et al.
Publicado: (2020)

A New Era in Understanding Diabetes Disparities Among U.S. Latinos—All Are Not Equal
por: López, Lenny, et al.
Publicado: (2014)

Reimbursement Policies for Diabetes Prevention Program (DPP): Implications for Racial and Ethnic Health Disparities
por: Formagini, Taynara, et al.
Publicado: (2021)

Socioeconomic Disparities Across the Spectrum of Genetic Burden in Type 2 Diabetes and Obesity Risk
por: Franks, Paul W.
Publicado: (2023)

Pregnancy, Pandemics, and Public Health Policy: The Disparate Impact of COVID-19 on Pregnant Immigrants
por: Fabi, Rachel E., et al.
Publicado: (2021)

Influenza vaccination: protecting the most vulnerable
por: Tanner, Alex R., et al.
Publicado: (2021)

Universal Alcohol/Drug Screening in Prenatal Care: A Strategy for Reducing Racial Disparities? Questioning the Assumptions
por: Roberts, Sarah C. M., et al.
Publicado: (2010)

The impact of new research technologies on our understanding of environmental causes of disease: the concept of clinical vulnerability
por: Vineis, Paolo, et al.
Publicado: (2009)

What Matters the Most for Hormonal Therapy in West Syndrome: Drug, Dosage, or Duration?
por: Sahu, Jitendra Kumar, et al.
Publicado: (2021)

Multitasking: Making the Most out of the Retroviral Envelope
por: Varela, Mariana, et al.
Publicado: (2010)

Strongyloidiasis: the most neglected tropical disease in Ethiopia
por: Tiruneh, Abebaw, et al.
Publicado: (2021)

Ferroptosis vulnerability in MYCN‐driven neuroblastomas
por: Dasgupta, Shayani, et al.
Publicado: (2022)

Intersectionality, vulnerability and foot health inequity
por: Almeida, Joana, et al.
Publicado: (2023)

Suicide risk in high school students: who are the most vulnerable groups?
por: da Silva, Laura Silva, et al.
Publicado: (2022)

National Institute on Minority Health and Health Disparities Specialized Centers of Excellence on Minority Health and Health Disparities
por: Mujuru, Priscah, et al.
Publicado: (2022)

Pre-treatment HIV drug resistance testing cost-effectiveness
por: van de Vijver, David AMC, et al.
Publicado: (2020)

The A's, G's, C's, and T's of health disparities
por: Ramos, Edward, et al.
Publicado: (2009)

One health disparities and COVID-19
por: Solis, Alma, et al.
Publicado: (2021)

Hearing Health Healthcare Disparities in Appalachia
por: Bush, Matthew L.
Publicado: (2021)

Cancer Disparities Experienced by People with Disabilities
por: Hughes, Rosemary B., et al.
Publicado: (2022)

Evidence from Toxicology: The Most Essential Science for Prevention
por: Mandrioli, Daniele, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4gjj5e9asd0dn0drffqc89fufa